APP · AppLovin Corporation
Was the Growth Scare Mispriced?
Executive Thesis
BUY with a $450 target: the market still prices a transient execution scare despite a platform compounding materially above the ad market. A unified auction, scarce mobile-app supply, and a partial next-generation model rollout drove 55% growth and an 84% adjusted EBITDA margin. The forensic caveats are material—model opacity, high receivables, concentrated voting control, and live litigation—but cash conversion and near-zero leverage sharply limit balance-sheet risk. Maintain a full position below $375, add on evidence of consumer durability, and trim above $500 absent estimate revisions.
Key Actionable Findings
Click any finding to interrogate with Andy ↗Frequently Asked Questions: APP
What is L2 Capital's investment rating and price target for APP?
L2 Capital currently maintains an institutional rating of BUY on AppLovin Corporation (APP) with a 12-month target price of $450.00 (implied return: +29.7%), backed by High conviction.
What is the core investment thesis for APP?
BUY with a $450 target: the market still prices a transient execution scare despite a platform compounding materially above the ad market. A unified auction, scarce mobile-app supply, and a partial next-generation model rollout drove 55% growth and an 84% adjusted EBITDA margin. The forensic caveats are material—model opacity, high receivables, concentrated voting control, and live litigation—but cash conversion and near-zero leverage sharply limit balance-sheet risk. Maintain a full position below $375, add on evidence of consumer durability, and trim above $500 absent estimate revisions.
What are APP's latest audited financial fundamentals?
According to audited SEC EDGAR filings, AppLovin Corporation reported total revenue of $5.48B (+16.4% YoY), Gross Margin of N/A, Free Cash Flow of N/A, and Net Debt of $1.03B.
What key risks and catalyst factors should investors monitor for APP?
- Q3 revenue increased 55% to $2.185 billion and exceeded the prior guidance ceiling by approximately $100 million despite only a partial rollout of the new model architecture.
- Q4 guidance calls for $2.365-$2.395 billion of revenue and $1.995-$2.025 billion of adjusted EBITDA, implying more than 50% full-year growth in both measures.
- Q3 free cash flow reached $1.418 billion, while net debt fell to approximately $342 million and the repurchase authorization increased to $3.6 billion.